A detailed history of Boothbay Fund Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 9,770 shares of EW stock, worth $662,015. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,770
Holding current value
$662,015
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $583,269 - $916,230
9,770 New
9,770 $644,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $868,593 - $1.14 Million
11,974 New
11,974 $1.14 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $417,619 - $562,894
6,028 New
6,028 $417,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $68,319 - $77,749
920 Added 21.11%
5,279 $436,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $103,269 - $132,209
-1,512 Reduced 25.75%
4,359 $325,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $304,192 - $396,221
3,693 Added 169.56%
5,871 $485,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $99,042 - $146,869
-1,145 Reduced 34.46%
2,178 $207,000
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $338,813 - $426,473
3,323 New
3,323 $391,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $517,963 - $647,207
-6,178 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $486,085 - $560,159
6,178 New
6,178 $517,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $65,617 - $101,412
-1,252 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $89,768 - $102,776
1,252 New
1,252 $292,000
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $76,260 - $93,457
-1,239 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $69,061 - $79,803
1,239 New
1,239 $229,000
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $67,165 - $85,694
-1,806 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $61,024 - $71,138
1,806
1,806 $204,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.